Dalfoni Banerjee

Dalfoni Banerjee is an award-winning, solution-focused consultant and entrepreneur. Beginning her career over 25 years ago in academic, pharmaceutical, and start-up biotechnology research laboratories – including Centocor and Merck –she went on to lead inspection-readiness efforts, drive clinical research and clinical operations, manage relationships between pharma and key opinion leaders, develop marketing strategies/tactics, and launch new drug products – across 12+ therapeutic categories.

In 2011, she founded 3Sixty Pharma Solutions, with a mission to partner with start up and established pharmaceutical, biotechnology, and medical device companies to help accelerate development & de-risk assets, boost marketing communications, and drive product launch.

Dalfoni is a board member, a mentor and advisor to life-science organizations, start-up incubators, and university innovation and technology transfer offices, chairs the Merck Sharp & Dohme Federal Credit Union Supervisory Committee, is an invited speaker and moderator on a variety of industry-related topics, has authored and co-authored several publications, and has received over 30 awards.